FR2846883B1 - Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide - Google Patents

Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide

Info

Publication number
FR2846883B1
FR2846883B1 FR0214012A FR0214012A FR2846883B1 FR 2846883 B1 FR2846883 B1 FR 2846883B1 FR 0214012 A FR0214012 A FR 0214012A FR 0214012 A FR0214012 A FR 0214012A FR 2846883 B1 FR2846883 B1 FR 2846883B1
Authority
FR
France
Prior art keywords
peptide
cosmetic
dermatological
pharmaceutical compositions
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0214012A
Other languages
English (en)
Other versions
FR2846883A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0214012A priority Critical patent/FR2846883B1/fr
Application filed by Vincience SA filed Critical Vincience SA
Priority to US10/534,355 priority patent/US7504092B2/en
Priority to DE60336756T priority patent/DE60336756D1/de
Priority to EP03767892A priority patent/EP1575605B1/fr
Priority to PCT/FR2003/003280 priority patent/WO2004043482A1/fr
Priority to AT03767892T priority patent/ATE505199T1/de
Priority to AU2003292326A priority patent/AU2003292326A1/en
Priority to ES03767892T priority patent/ES2360388T3/es
Publication of FR2846883A1 publication Critical patent/FR2846883A1/fr
Application granted granted Critical
Publication of FR2846883B1 publication Critical patent/FR2846883B1/fr
Priority to US12/071,002 priority patent/US7674451B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0214012A 2002-11-08 2002-11-08 Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide Expired - Fee Related FR2846883B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0214012A FR2846883B1 (fr) 2002-11-08 2002-11-08 Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide
DE60336756T DE60336756D1 (de) 2002-11-08 2003-11-04 Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
EP03767892A EP1575605B1 (fr) 2002-11-08 2003-11-04 Composition cosmetique ou pharmaceutique comprenant des peptides possedant le motif arg-gly-ser
PCT/FR2003/003280 WO2004043482A1 (fr) 2002-11-08 2003-11-04 Composition cosmetique ou pharmaceutique comprenant des peptides, possedant le motif arg-gly-ser
US10/534,355 US7504092B2 (en) 2002-11-08 2003-11-04 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
AT03767892T ATE505199T1 (de) 2002-11-08 2003-11-04 Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
AU2003292326A AU2003292326A1 (en) 2002-11-08 2003-11-04 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
ES03767892T ES2360388T3 (es) 2002-11-08 2003-11-04 Composición cosmética o farmacéutica que contiene péptidos con la secuencia arg-gly-ser.
US12/071,002 US7674451B2 (en) 2002-11-08 2008-02-14 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214012A FR2846883B1 (fr) 2002-11-08 2002-11-08 Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide

Publications (2)

Publication Number Publication Date
FR2846883A1 FR2846883A1 (fr) 2004-05-14
FR2846883B1 true FR2846883B1 (fr) 2004-12-24

Family

ID=32116475

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0214012A Expired - Fee Related FR2846883B1 (fr) 2002-11-08 2002-11-08 Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide

Country Status (2)

Country Link
ES (1) ES2360388T3 (fr)
FR (1) FR2846883B1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3034664B1 (fr) 2015-04-09 2018-09-14 ISP Investments LLC. Extrait hydro-alcoolique de schinus molle, compositions cosmetiques le comprenant et leurs utilisations cosmetiques
FR3043695B1 (fr) 2015-11-17 2019-10-25 ISP Investments LLC. Procede d'obtention d'un extrait aqueux enrichi en petits arn a partir d'une matiere vegetal et extraits issus du procede
FR3048610B1 (fr) 2016-03-08 2020-03-27 ISP Investments LLC. Corps gras active et/ou cire activee au moyen de la fraction non hydrosoluble du suc de carica papaya
KR102230390B1 (ko) 2016-09-07 2021-03-23 아이에스피 인베스트먼츠 엘엘씨 프루누스 페르시카의 수성 추출물 및 그의 제조 방법
FR3062568B1 (fr) 2017-02-09 2020-10-23 Isp Investments Llc Extraits de la liane marsdenia cundurango, compositions cosmetiques les comprenant et leurs utilisations cosmetiques.
CN108721155B (zh) 2017-04-14 2023-03-17 Isp投资有限公司 含有白松露提取物的化妆品制备物和其化妆方法
FR3066113B1 (fr) 2017-05-12 2020-06-05 ISP Investments LLC. Procede d’obtention d’un extrait aqueux d’anethum graveolens enrichi en petits arn
FR3077204B1 (fr) 2018-01-30 2021-09-17 Isp Investments Llc Extraits de fruit de myrciaria dubia riche en acides organiques, compositions cosmetiques le comprenant et leurs utilisations cosmetiques
FR3091993B1 (fr) 2019-01-29 2021-01-22 Isp Investments Llc Procede d’obtention d’un extrait de feuilles de patchouli et ses utilisations cosmetiques
FR3106754B1 (fr) 2020-02-04 2022-01-07 Isp Investments Llc Procede d’obtention d’un extrait aqueux de lavande, compositions comprenant un tel extrait et leurs utilisations cosmetiques
FR3110425B1 (fr) 2020-05-19 2022-09-09 Isp Investments Llc Procede d’obtention d’un extrait de bois de santal, compositions le comprenant et ses utilisations cosmetiques
CN114081852A (zh) 2020-08-25 2022-02-25 Isp投资有限公司 改善皮肤外观的组合物和方法
FR3116438B1 (fr) 2020-11-23 2022-10-14 Isp Investments Llc Procede d’obtention d’extraits aqueux de feuilles de thes, compositions comprenant de tels extraits et leurs utilisations cosmetiques
FR3125425B1 (fr) 2021-07-22 2024-09-13 Isp Invest Llc Extrait de feuilles de the noir, compositions le comprenant et ses utilisations cosmetiques
FR3146596A1 (fr) 2023-03-15 2024-09-20 ISP Investments LLC. Procede d’obtention d’un extrait de bois de rose, compositions le comprenant et ses utilisations cosmetiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2738746B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.

Also Published As

Publication number Publication date
FR2846883A1 (fr) 2004-05-14
ES2360388T3 (es) 2011-06-03

Similar Documents

Publication Publication Date Title
FR2846883B1 (fr) Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
EP2266590A3 (fr) Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
WO2002048183A3 (fr) Compositions de cristaux de peptides
MXPA03007358A (es) Transportadores que contienen porciones de arginina separadas.
CA2411754A1 (fr) Acide 4-¬(4-chloro-2-hydroxybenzoyl)amino|butanoique et compositions d'administration d'agents actifs
EP1188768A3 (fr) Peptides antagonistes de LHRH
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
WO2003064449A3 (fr) Peptides bioactifs de keratine
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
WO2005115174A3 (fr) Conjugues dipeptidiques antagonistes de l’alpha-msh
CA2303498A1 (fr) Acides dioxocyclopentylhydroxamiques
NO20031159D0 (no) Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner
AU2001296431A1 (en) Tgf-beta inhibitors and methods
AU2003231471A1 (en) Antimicrobial polypeptide and utizliation thereof
AR015498A1 (es) Composiciones de edulcorante de mesa.
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
BR0211186A (pt) peptìdeos e uso dos mesmos no escurecimento da pele
HK1079549A1 (en) Muteins of placental growth factor type 1, preparation method and application thereof
WO2002034202A3 (fr) Composes antioxydants comprenant plusieurs composants, compositions pharmaceutiques contenant ces composes et utilisation de ceux-ci dans la reduction ou la prevention du stress oxydatif
WO2001005810A3 (fr) DERIVES PEPTIDIQUES CYCLIQUES SERVANT D'INHIBITEURS DE L'INTEGRINE αVβ¿6?
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
AU7683296A (en) Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
SE9503679D0 (sv) Antioxidants
CA2272880A1 (fr) Composition et procede permettant de reduire la sensation d'irritation de la peau

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

ST Notification of lapse

Effective date: 20200910